Patent details
EP3781132 Title: APIXABAN FORMULATIONS
Basic Information
- Publication number:
- EP3781132
- PCT Application Number:
- US2019027456
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP197223332
- PCT Publication Number:
- WO2019204193
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- APIXABAN FORMULATIONS
- French Title of Invention:
- FORMULATIONS D'APIXABAN
- German Title of Invention:
- APIXABAN-FORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 15/04/2019
- Grant date:
- 20/03/2024
- EP Publication Date:
- 24/02/2021
- PCT Publication Date:
- 24/10/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/03/2024
- EP B1 Publication Date:
- 20/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/04/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2024
- Name:
- Bristol-Myers Squibb Company
- Address:
- Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)
- Name:
- Pfizer Inc.
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 26/03/2024
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KUNTZ, Daniel
- Address:
- United States (US)
2
- Name:
- BADAWY, Sherif, Ibrahim, Farag
- Address:
- United States (US)
3
- Name:
- STEVENS, Timothy, D.
- Address:
- United States (US)
4
- Name:
- WAYBRANT, Brett
- Address:
- United States (US)
Priority
- Priority Number:
- 201862658175 P
- Priority Date:
- 16/04/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/16; A61K 31/4545; A61P 7/02;
Publication
European Patent Bulletin
1
- Issue number:
- 202412
- Publication date:
- 20/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202504
- Publication date:
- 22/01/2025
- Description:
- Opposition procedure started
3
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/04/2026
- Annual Fee Number:
- 8
- Annual Fee Amount:
- 99 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 16/04/2025
- Last Annual Fee Paid Number:
- 7
- Last Annual Fee Paid Amount:
- 82 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 26/03/2024 | Power Of Attorney | 1 |
| 26/03/2024 | Outgoing Correspondence | 1 |